medroxyprogesterone acetate has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burlando, AM; Flynn, AN; Gutman, S; McAllister, A; Roe, AH; Schreiber, CA; Sonalkar, S | 1 |
| Rubin, SE; Shroff, N; Smith, TJ; Urdanigo, TK | 1 |
| Aronstam, A; Karlin, J; Katz, M; Newmark, RL; O'Grady, N; Rafie, S; Strome, S | 1 |
3 other study(ies) available for medroxyprogesterone acetate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
Topics: Contraception; Contraceptive Agents, Female; COVID-19; Drug Prescriptions; Family Planning Services; Female; Health Services Accessibility; Healthcare Disparities; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Patient Acceptance of Health Care; SARS-CoV-2; Self Administration; United States | 2021 |
Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
Topics: Contraceptive Agents, Female; COVID-19; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Pandemics; Patient Satisfaction | 2023 |
An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
Topics: Adolescent; Adult; California; Contraceptive Agents, Hormonal; COVID-19; Female; Hormonal Contraception; Humans; Injections, Subcutaneous; Medicaid; Medroxyprogesterone Acetate; Middle Aged; Patient Acceptance of Health Care; Primary Health Care; Safety-net Providers; Self Administration; Telemedicine; United States; Young Adult | 2020 |